Objective:

To investigate the role of lysine crotonylation in colorectal cancer (CRC) proliferation and the effects of CDK1 decrotonylation on tumor growth and apoptosis.

Approach:

Key Findings:

• Significant elevation of global crotonylation in colorectal tumor specimens compared to adjacent normal tissues.
• Decrotonylation of CDK1-K9 inhibited colorectal tumor proliferation and migration by arresting the cell cycle at the G2/M phase and inducing apoptosis.
• Histone acetyltransferase hMOF and histone deacetylase HDAC1 co-mediated CDK1 K9 crotonylation.
• Decrotonylated mutation decreased the interaction of CDK1 with cyclin and reduced kinase activity.
• CDK1 K9 decrotonylation and CDK1 inhibitor RO-3306 exhibited synergistic effects.

Interpretation:

The study reveals the role of non-histone protein crotonylation in regulating CRC proliferation and migration, highlighting the potential of targeting CDK1 decrotonylation in cancer therapy to improve treatment outcomes.

Limitations:

• Limited exploration of other potential crotonylation sites and their effects on CRC, which may provide additional insights.
• The study primarily focuses on CDK1 without extensive investigation into other proteins involved in CRC proliferation, potentially overlooking important interactions.

Conclusion:

Decrotonylation of CDK1 impairs CRC growth and enhances sensitivity to CDK1 inhibitors, suggesting a novel mechanism in CRC regulation that could inform future therapeutic strategies.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.